Compile Data Set for Download or QSAR
Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 10285
TargetHemagglutinin(Influenza A virus (A/reassortant/NIBRG-121(Califor...)
SociÉTÉ

US Patent
LigandPNGBDBM525149(US10988505, Comparative #1)
Affinity DataEC50:  5.07E+3nMAssay Description:The ability of the tested compound to block influenza virus replication (PR8 and X31) in Calu-3 human bronchial epithelial cells was evaluated as des...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetHemagglutinin(Influenza A virus (strain A/X-31 H3N2))
SociÉTÉ

US Patent
LigandPNGBDBM525149(US10988505, Comparative #1)
Affinity DataEC50:  7.70E+3nMAssay Description:The ability of the tested compound to block influenza virus replication (PR8 and X31) in Calu-3 human bronchial epithelial cells was evaluated as des...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetHemagglutinin(Influenza A virus (strain A/X-31 H3N2))
SociÉTÉ

US Patent
LigandPNGBDBM236493(US9365853, 4 | US10988505, Comparative #2)
Affinity DataEC50:  5.69E+3nMAssay Description:The ability of the tested compound to block influenza virus replication (PR8 and X31) in Calu-3 human bronchial epithelial cells was evaluated as des...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetHemagglutinin(Influenza A virus (A/reassortant/NIBRG-121(Califor...)
SociÉTÉ

US Patent
LigandPNGBDBM525151(US10988505, Example 1)
Affinity DataEC50:  27.3nMAssay Description:The ability of the tested compound to block influenza virus replication (PR8 and X31) in Calu-3 human bronchial epithelial cells was evaluated as des...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetHemagglutinin(Influenza A virus (strain A/X-31 H3N2))
SociÉTÉ

US Patent
LigandPNGBDBM525151(US10988505, Example 1)
Affinity DataEC50:  20.9nMAssay Description:The ability of the tested compound to block influenza virus replication (PR8 and X31) in Calu-3 human bronchial epithelial cells was evaluated as des...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetHemagglutinin(Influenza A virus (A/reassortant/NIBRG-121(Califor...)
SociÉTÉ

US Patent
LigandPNGBDBM525152(US10988505, Example 2 | N-0385 | Ms-QFR-kbt)
Affinity DataEC50:  1.56nMAssay Description:The ability of the tested compound to block influenza virus replication (PR8 and X31) in Calu-3 human bronchial epithelial cells was evaluated as des...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetHemagglutinin(Influenza A virus (strain A/X-31 H3N2))
SociÉTÉ

US Patent
LigandPNGBDBM525152(US10988505, Example 2 | N-0385 | Ms-QFR-kbt)
Affinity DataEC50:  9.33nMAssay Description:The ability of the tested compound to block influenza virus replication (PR8 and X31) in Calu-3 human bronchial epithelial cells was evaluated as des...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetHemagglutinin(Influenza A virus (A/reassortant/NIBRG-121(Califor...)
SociÉTÉ

US Patent
LigandPNGBDBM525153(US10988505, Example 3 | N-0386 | Ac-QFR-kbt)
Affinity DataEC50:  2.28nMAssay Description:The ability of the tested compound to block influenza virus replication (PR8 and X31) in Calu-3 human bronchial epithelial cells was evaluated as des...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetHemagglutinin(Influenza A virus (strain A/X-31 H3N2))
SociÉTÉ

US Patent
LigandPNGBDBM525153(US10988505, Example 3 | N-0386 | Ac-QFR-kbt)
Affinity DataEC50:  34nMAssay Description:The ability of the tested compound to block influenza virus replication (PR8 and X31) in Calu-3 human bronchial epithelial cells was evaluated as des...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetTransmembrane protease serine 6(Human)
SociÉTÉ

US Patent
LigandPNGBDBM525149(US10988505, Comparative #1)
Affinity DataKi:  0.0110nMAssay Description:Enzymatic assays and Ki determination were performed at room temperature in an assay buffer containing 50 mM Tris-HCl, 150 mM NaCl and 500 μg/mL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetTransmembrane protease serine 6(Human)
SociÉTÉ

US Patent
LigandPNGBDBM236493(US9365853, 4 | US10988505, Comparative #2)
Affinity DataKi:  0.0880nMAssay Description:Enzymatic assays and Ki determination were performed at room temperature in an assay buffer containing 50 mM Tris-HCl, 150 mM NaCl and 500 μg/mL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetTransmembrane protease serine 6(Human)
SociÉTÉ

US Patent
LigandPNGBDBM525151(US10988505, Example 1)
Affinity DataKi:  0.134nMAssay Description:Enzymatic assays and Ki determination were performed at room temperature in an assay buffer containing 50 mM Tris-HCl, 150 mM NaCl and 500 μg/mL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetTransmembrane protease serine 6(Human)
SociÉTÉ

US Patent
LigandPNGBDBM525153(US10988505, Example 3 | N-0386 | Ac-QFR-kbt)
Affinity DataKi:  0.506nMAssay Description:Enzymatic assays and Ki determination were performed at room temperature in an assay buffer containing 50 mM Tris-HCl, 150 mM NaCl and 500 μg/mL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent

TargetTransmembrane protease serine 6(Human)
SociÉTÉ

US Patent
LigandPNGBDBM525152(US10988505, Example 2 | N-0385 | Ms-QFR-kbt)
Affinity DataKi:  2.63nMAssay Description:Enzymatic assays and Ki determination were performed at room temperature in an assay buffer containing 50 mM Tris-HCl, 150 mM NaCl and 500 μg/mL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2022
Entry Details
Go to US Patent